Sign In
Buy ZTS
$77.59
+1.20 (+1.57%)
At Close: Jun 03, 2026
Zoetis: Focusing On The High Margin Segments
04:35pm, Thursday, 13'th Mar 2025
The recent divestiture of the MFA segment improves margins and returns on capital. Zoetis is focusing on more profitable segments like genetics and companion animals. The recently updated Librela labe
Zoetis Inc. (ZTS) CFO Wetteny Joseph Hosts Barclays 27th Annual Global Healthcare (Transcript)
01:00pm, Tuesday, 11'th Mar 2025
Zoetis Inc. (NYSE:ZTS ) Barclays 27th Annual Global Healthcare March 11, 2025 10:30 AM ET Company Participants Wetteny Joseph - Chief Financial Officer Conference Call Participants Balaji Prasad - Bar
Zoetis (ZTS) Laps the Stock Market: Here's Why
07:15pm, Friday, 07'th Mar 2025
Zoetis (ZTS) reachead $170.37 at the closing of the latest trading day, reflecting a +1.87% change compared to its last close.
My Top 15 High-Growth Dividend Stocks For March 2025
04:34pm, Monday, 03'rd Mar 2025
The SPDR S&P 500 ETF Trust stumbled in February but managed to maintain a positive return in 2025. The Top 15 dividend growth stocks for March 2025 offer an average dividend yield of 1.13% and appear
Zoetis Inc. (ZTS) BofA Securities 2025 Animal Health Summit (Transcript)
05:29pm, Friday, 28'th Feb 2025
Zoetis Inc. (NYSE:ZTS ) BofA Securities 2025 Animal Health Summit February 27, 2025 1:20 PM ET Company Participants Wetteny Joseph - CFO Conference Call Participants Michael Ryskin - Bank of America O
A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now
08:00am, Sunday, 23'rd Feb 2025
It is a beautiful thing when you find a feel-good stock that offers market-beating potential. A perfect example of this combination today is animal healthcare specialist Zoetis (ZTS 1.93%).
Zoetis CEO on bird flu vaccine
12:25pm, Tuesday, 18'th Feb 2025
Zoetis received a conditional license for its bird flu vaccine from the US Department of Agriculture to help fight the spread of the disease on poultry farms. Here's what CEO Kristin Peck had to say
Why Zoetis Stock Took Another Tumble Today
05:15pm, Friday, 14'th Feb 2025
One day after unveiling quarterly results that disappointed the market and engendered a stock sell-off, Zoetis (ZTS -4.49%) shares again tumbled. As of late-session trading on Friday, they were down b
US grants conditional clearance to Zoetis' bird flu vaccine for poultry
01:16pm, Friday, 14'th Feb 2025
Zoetis said on Friday its bird flu vaccine has received the U.S. Department of Agriculture's conditional license for use in poultry.
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
01:00pm, Friday, 14'th Feb 2025
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #HPAI--Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional lice
Zoetis CEO says Avian Flu vaccine for poultry gets USDA approval
05:12pm, Thursday, 13'th Feb 2025
Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more.
Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity
04:43pm, Thursday, 13'th Feb 2025
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance, presenting a buying opportunity around $163/share. Zoetis' unique advantages and pricing powe
Zoetis Stock Down Despite Q4 Earnings & Revenues Beat Estimates
12:31pm, Thursday, 13'th Feb 2025
ZTS stock falls despite better-than-expected fourth-quarter results due to a weak 2025 outlook.
Zoetis Inc. (ZTS) Q4 2024 Earnings Call Transcript
12:27pm, Thursday, 13'th Feb 2025
Zoetis Inc. (NYSE:ZTS ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Steve Frank - IR Kristin Peck - CEO Wetteny Joseph - CFO Conference Call Participants Michael
Why Zoetis Stock Was Falling Today
12:24pm, Thursday, 13'th Feb 2025
Shares of Zoetis (ZTS -6.17%), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up short in its fourth quarter.
